Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVO · against 596 other Healthcare companies listed in US-listed
Ranked #372 of 597 · scores higher than 38% of peers · safety percentile 30
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 20–29, including EVO · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | EVO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.71× | 0.23× | 28% | 33% | |
| BetaLower is better · 556 reported | 1.26 | 0.95 | 32% | 33% | |
| Current ratioHigher is better · 600 reported | 2.33× | 3.91× | 33% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 368 | 189.3B USD | 30 | 45 | |
| 369 | 1.7B USD | 30 | 35 | |
| 370 | 433M USD | 30 | 81 | |
| 371 | 327M USD | 30 | 11 | |
| 372 | 551M USD | 30 | 27 | |
| 373 | 78.1B USD | 30 | 60 | |
| 374 | 15.7B USD | 29 | 33 | |
| 375 | 133M USD | 29 | 51 | |
| 376 | 1.5B USD | 29 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score